Use of conjoint analysis to assess HIV vaccine acceptability: Feasibility of an innovation in the assessment of consumer health-care preferences

International Journal of STD and AIDS

Volumn 23, Issue 4, 2012, Pages 235-241

  Lee, S J ^a   Newman, P A ^b   Comulada, W S ^a   Cunningham, W E ^c   Duan, N ^d,e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d Och Spine at New York Presbyterian Hospitals   (United States)

^e NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

Conjoint analysis; Consumer preferences; Discrete choice experiment; Feasibility; HIV; HIV vaccine acceptability; Partial efficacy

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

ABORIGINE; ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; CLINICAL ASSESSMENT; CONJOINT ANALYSIS; CONSUMER; CONTROLLED STUDY; DRUG COST; DRUG EFFICACY; DRUG SAFETY; DRUG USE; ETHNIC GROUP; EVIDENCE BASED MEDICINE; FEASIBILITY STUDY; FEMALE; HEALTH CARE ACCESS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PATIENT PREFERENCE; POPULATION EXPOSURE; PRIORITY JOURNAL; STATISTICAL ANALYSIS; THAILAND; TREATMENT DURATION; UNITED STATES;

ADOLESCENT; ADULT; AIDS VACCINES; CANADA; ETHNIC GROUPS; HIV INFECTIONS; HUMANS; LOS ANGELES; MALE; PATIENT ACCEPTANCE OF HEALTH CARE; STATISTICS AS TOPIC; YOUNG ADULT;

EID: 84861538922     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/ijsa.2011.011189     Document Type: Article

References (34)

1. Elias C, Coggins C. Acceptability research on female-controlled barrier methods to prevent heterosexual transmission of HIV: where have we been? Where are we going? J Women's Health Gend Based Med 2001;10:163-173
2. Newman PA, Logie C. HIV vaccine acceptability: A systematic review and meta-analysis. AIDS 2010;10:1749-1756
3. Hall HI, Song R, Rhodes P, et al. Estimation of HIV Incidence in the United States,' JAMA 2008;300:520-529
4. UNAIDS. 'Report on the Global AIDS Epidemic,' Geneva, UNAIDS, 2008
5. Newman PA, Duan N, Rudy ET, Anton PA. Challenges for HIV vaccine dissemination and clinical trial recruitment: if we build it, will they come? AIDS Patient Care STDs 2004;18:691-701
6. Newman PA, Lee S-J, Rudy ET, et al. HIV vaccine acceptability among a random sample of adults in Los Angeles (LA VOICES), Health Serv Res 2009;44:2167-2179
7. Esparza J, Chang ML, Widdus R, Madrid Y, Walker N, Ghys PD. Estimation of 'needs' and 'probable uptake' for HIV/AIDS preventive vaccines based on possible policies and likely acceptance (WHO/UNAIDS/IAVI study). Vaccine 2003;21:2032-2041
8. Institute of Medicine, Committee on Quality of Health Care in America. Crossing the Quality Chasm: A New Health System for the 21st century. Washington, DC: National Academy Press, 2001
9. Rerks-Ngarm S, Pitisuttithum P, Nitayaphan S, et al. Vaccination with ALVAC and IDSVAX to prevent HIV-1 infection in Thailand. N Engl J Med 2009;361:2209-2220
10. Green PE, Srinivasan V. Conjoint analysis in marketing: New developments with implications for research and practice. J Mark Res 1990;54:3-19
11. Bunch WH, Chapman RG. Patient preferences in surgery for scoliosis. J Bone Joint Surg Am 1985;67:794-799
12. Cattin P, Wittink DR. Commercial use of conjoint analysis: a survey. J Mark 1989;46:44-53
13. Hay JW. Conjoint analysis in pharmaceutical research. J Manag Care Pharm 2002;8:206-208
14. Holt BY, Morwitz VG, Ngo L, et al. Microbicide preference among young women in California. J Womens Health 2006;15:281-294
15. Phillips KA, Johnson FR, Maddala T. Measuring what people value: a comparison of 'attitude' and 'preference' surveys. Health Serv Res 2002;37:1659-1679
16. Phillips KA, Van Bebber S, Marshall D, Walsh J, Thabane L. A review of studies examining stated preferences for cancer screening. Prev Chronic Dis 2006;3:A75
17. Fraenkel L, Wittink DR, Concato J, Fried T. Informed choice and the widespread use of antiinflammatory drugs. Arthritis Rheum 2004;51:210-214
18. Meister H, Lausberg I, Kiessling J, von Wedel H, Walger M. Identifying the needs of elderly, hearing-impaired persons: the importance and utility of hearing aid attributes. Eur Arch Otorhinolaryngol 2002;259: 531-534
19. Bhargava JS, Patel B, Foss AJE, Avery AJ, King AJ. Views of glaucoma patients on aspects of their treatment: An assessment of patient preference by conjoint analysis. Inves Ophthalmol Vis Sci 2006;47:2885-2888
20. Kellet N, West F, Finlay AY. Conjoint analysis: a novel, rigorous tool for determining patient preferences for topical antibiotic treatment for acne. A randomised controlled trial. Br J Dermatol 2006;154:524-532
21. Liau A, Zimet G, Fortenberry JD. Attitudes about human immunodeficiency virus immunization: the influence of health beliefs and vaccine characteristics. Sex Transm Dis 1998;25:76-81
22. Zimet GD, Blythe MJ, Fortenberry JD. Vaccine characteristics and acceptability of HIV immunization among adolescents. Int J STD AIDS 2000;11:143-149
23. Lee S-J, Brooks RA, Newman PA, Seiden S, Santhong R, Duan N. HIV vaccine acceptability among immigrant Thai residents in Los Angeles: a mixed-method approach. AIDS Care 2008;20:1161-1168
24. Newman PA, Duan N, Lee S-J, et al. HIV vaccine acceptability among communities at risk: The impact of vaccine characteristics. Vaccine 2006;24:2001-2094
25. Frankel MR, Shapiro MF, Duan N, et al. National probability samples in studies of low-prevalence diseases. Part II: designing and implementing the HIV cost and services utilization study sample. Health Serv Res 1999;34:969-992
26. Ryan M, McIntosh E, Shackley P. Methodological issues in the application of conjoint analysis in health care. Health Econ 1998;7:373-378
27. Plackett RL, Burman JP. The design of optimum multifactorial experiments. Biometrika, 1946;33:305-325
28. Newman PA, Duan N, Rudy ET, Roberts KJ, Swendeman D. Post-trial HIV vaccine adoption: concerns, motivators, and intentions among persons at risk for HIV. J Acquir Immune Defic Syndr 2004;37:1393-1403
29. Newman PA, Duan N, Rudy ET, Johnston-Roberts K. HIV risk and prevention in a post-vaccine context. Vaccine 2004;221:1954-1963
30. Newman PA, Woodford MR, Logie C. HIV vaccine acceptability and culturally appropriate dissemination among sexually diverse Aboriginal peoples in Canada. Global Public Health 2012;1:87-100
31. Daniels D, Ruth B, Klevens M, Herrera GA. Undervaccinated African-American preschoolers: a case of missed opportunities. Am J Prev Med 2001;20:61-68
32. Gore P, Madhavan S, Curry D, et al. Predictors of childhood immunization completion in a rural population. Soc Sci Med 1999;48:1011-1027
33. Lopreiato JO, Ottolini MC. Assessment of immunization compliance among children in the Department of Defense health care system. Pediatrics 1996;97:308-311
34. Sawaya GF, Smith-McCune K. HPV vaccination - more answers, more questions. N Engl J Med 2007;356:1991-1993